Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −3 vs. Q1 2024
- Shares held
- 6.25M
- −1.02M (−14.1%) vs. Q1 2024
- Total value
- $4.68M
- −$3.03M (−39.3%) vs. Q1 2024
- New holders
- 2
- 11 more added
- Sold out
- 5
- 11 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 279 | $0 | 0.00% | +58+26.2% | Added |
| BNP Paribas Arbitrage, SA | 24 | $18 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $56 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $75 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $75 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $207 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $221 | 0.00% | −16−5.1% | Reduced |
| Financial Perspectives, Inc | 310 | $233 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $255 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $295 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 431 | $323 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 469 | $352 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 480 | $360 | 0.00% | −25−5.0% | Reduced |
| Simplex Trading, LLC | 2,101 | $1.00K | 0.00% | −2,606−55.4% | Reduced |
| Group One Trading, L.P. | 1,600 | $1.20K | 0.00% | −8−0.5% | Reduced |
| Citigroup Inc | 5,165 | $3.87K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,522 | $6.39K | 0.00% | +122+1.5% | Added |
| Tower Research Capital LLC (TRC) | 9,618 | $7.21K | 0.00% | +2,340+32.2% | Added |
| Brinker Capital Investments, LLC | 10,136 | $7.60K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $7.60K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $8.26K | 0.00% | 00.0% | Unchanged |
| Nixon Peabody Trust Co | 11,126 | $8.35K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,077 | $10.6K | 0.00% | +14,077 | New |
| Kestra Advisory Services, LLC | 15,359 | $11.5K | 0.00% | +2,412+18.6% | Added |
| Northern Trust Corp | 34,023 | $25.5K | 0.00% | −56−0.2% | Reduced |
| Millennium Management LLC | 36,567 | $27.4K | 0.00% | −17,112−31.9% | Reduced |
| Intellectus Partners, LLC | 53,312 | $40.0K | 0.01% | −430−0.8% | Reduced |
| State Street Corp | 56,611 | $42.5K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 74,074 | $55.6K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 92,958 | $69.7K | 0.01% | +66,129+246.5% | Added |
| Two Sigma Advisers, LP | 93,600 | $70.2K | 0.00% | −3,500−3.6% | Reduced |
| Susquehanna International Group, LLP | 98,603 | $74.0K | 0.00% | +1,821+1.9% | Added |
| Citadel Advisors LLC | 99,844 | $74.9K | 0.00% | +73,388+277.4% | Added |
| Bridgeway Capital Management, LLC | 138,495 | $103.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 157,972 | $118.5K | 0.00% | −11,929−7.0% | Reduced |
| Alphabet Inc. | 189,122 | $141.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 272,955 | $204.8K | 0.00% | +6,059+2.3% | Added |
| HighTower Advisors, LLC | 341,570 | $251.0K | 0.00% | +341,570 | New |
| BlackRock Inc. | 354,788 | $266.1K | 0.00% | +22,702+6.8% | Added |
| Renaissance Technologies LLC | 483,902 | $362.9K | 0.00% | −36,198−7.0% | Reduced |
| EPIQ Capital Group, LLC | 852,361 | $639.3K | 0.23% | +6,588+0.8% | Added |
| Vanguard Group Inc | 1,214,621 | $911.0K | 0.00% | +83,091+7.3% | Added |
| Tang Capital Management LLC | 1,500,000 | $1.13M | 0.11% | −1,447,652−49.1% | Reduced |
| Scharf Investments, LLC | 0 | $0 | 0.00% | −91,061−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −22,523−100.0% | Sold out |
| Westmount Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −268−100.0% | Sold out |